Maja Thurley-Rothenberg

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy.

TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy.

Journal: Leukemia
Published: March 18, 2026

Clonal hematopoiesis in AML long-term survivors: Risk factors and clinical consequences.

Clonal hematopoiesis in AML long-term survivors: Risk factors and clinical consequences.

Journal: HemaSphere
Published: March 11, 2025

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).

Journal: Leukemia
Published: January 28, 2025

Quality of life and life satisfaction in long-term survivors of acute myeloid leukemia.

Quality of life and life satisfaction in long-term survivors of acute myeloid leukemia.

Journal: Leukemia
Published: January 24, 2025

Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation.

Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation.

Journal: Blood advances
Published: September 09, 2024

Prognostic impact of CEBPA mutational subgroups in adult AML.

Prognostic impact of CEBPA mutational subgroups in adult AML.

Journal: Leukemia
Published: October 30, 2023

Friday Leukemia-a Structural Phenomenon.

Friday Leukemia-a Structural Phenomenon.

Journal: Deutsches Arzteblatt international
Published: July 05, 2023

Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG).

Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG).

Journal: Leukemia
Published: June 24, 2023

Modeling early treatment response in AML from cell-free tumor DNA.

Modeling early treatment response in AML from cell-free tumor DNA.

Journal: iScience
Published: June 16, 2023

Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome.

Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome.

Journal: British journal of haematology
Published: April 15, 2023

Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia.

Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia.

Journal: Leukemia
Published: January 19, 2023

Progressive disruption of hematopoietic architecture from clonal hematopoiesis to MDS.

Progressive disruption of hematopoietic architecture from clonal hematopoiesis to MDS.

Journal: iScience
Published: September 11, 2022
Showing 1-12 of 40

Last Updated: 09/26/2026